The Hemostats Market Size was valued at USD 2.74 billion in 2023 and is expected to reach USD 4.93 billion by 2032 and grow at a CAGR of 6.76% over the forecast period 2024-2032.
To Get More Information on Hemostats Market - Request Sample Report
This report emphasizes the rising incidence and prevalence of trauma and surgery cases, which are driving demand for sophisticated hemostatic products. The research analyzes prescription and usage patterns of hemostats by region, taking into account differences in medical practice and availability. It also explores healthcare expenditure on hemostatic products, breaking down government, commercial, private, and out-of-pocket spending. The study also delves into R&D spending and innovation in hemostats, particularly the creation of next-generation products for better surgical outcomes. Additionally, it examines the influence of regulatory policies and safety regulations on market trends, dictating product approvals, compliance, and industry growth as a whole.
Drivers
Cardiovascular diseases, as reported by the WHO, claim 17.9 million lives each year, prompting an increase in surgical procedures demanding hemostatic agents. Minimally invasive surgeries (MIS) adoption is also contributing to demand since surgeons need precision hemostats to manage small incisional bleeding. Also, advancements in bioengineered hemostatic agents, like fibrin and thrombin-based products, are improving their efficiency and uptake. The surge in emergency and war trauma cases has further boosted the application of hemostats in first-response care and battlefield medicine. Government efforts and positive reimbursement policies in developed nations are also driving market growth by making high-end hemostatic solutions affordable. In addition, leaders like Johnson & Johnson, Medtronic, and Baxter keep investing in R&D, introducing innovative products that enhance bleeding control efficiency and minimize post-surgery complications. With the growing worldwide aging population, projected to reach 1.5 billion by 2050, demand for surgeries and, by extension, hemostats will keep increasing, fueling continued market growth.
Restraints
Most of the next-generation hemostats, including fibrin sealants and combination hemostats, are costly, thereby limiting their use by small health facilities and lower-income patients in regions. Furthermore, the risk of adverse reactions, including immunogenic responses, infections, and tissue toxicity, hinders their universal application. Research has shown that certain thrombin-based hemostats have risks of viral transmission and hypersensitivity reactions, which pose a concern to surgeons and regulatory authorities. Stringent regulatory clearances by bodies such as the FDA and EMA are also a challenge, as manufacturers have to adhere to high safety and efficacy benchmarks before new products can be introduced to market. The short shelf life of biological hemostats still contributes to supply chain issues, resulting in wastage and added cost. In addition, low knowledge levels and training gaps among healthcare professionals in the emerging economies hold back the uptake of advanced hemostatic agents. Hospitals and clinics in cost-conscious markets prefer conventional techniques such as electrocautery or manual compression, lowering the need for commercial hemostats. These considerations in combination limit market penetration and slow the uptake of new hemostatic solutions.
Opportunities
Nanotechnology-based hemostats and regenerative medicine innovations are transforming bleeding control solutions, providing profitable prospects for market participants. Novel bioabsorbable hemostats with minimal post-operative complications and removal requirements are increasingly finding favor. Furthermore, increased incidence of trauma cases, road accidents (1.3 million deaths every year), and war wounds is propelling demand for fast-acting, compact hemostatic agents in emergency applications. The growing investments in healthcare infrastructure in emerging markets such as India, China, and Brazil present huge growth opportunities, with these nations witnessing an increasing number of surgical procedures and enhanced access to healthcare. In addition, strategic partnerships and acquisitions between major players are driving innovation. For example, Baxter's acquisition of Seprafilm from Sanofi broadened its portfolio of hemostatic products, enhancing its market share. The increasing trend of personalized medicine also presents a chance to create targeted hemostatic products for particular surgical requirements. With the advancements in 3D bioprinting and tissue engineering, firms can produce next-generation hemostats that improve surgical outcomes, driving long-term market growth.
Challenges
Surgeons need accurate, trustworthy hemostats, yet elements like variations in blood coagulation between patients, operation intricacy, and tissue compatibility impact product efficacy. A further top challenge lies with the variability in clinical standards and procedures and guides for using a hemostat that exist at an inconsistent basis of adoption from hospitals and among territories. Also, disruptions to the supply chain resulting from situations such as the COVID-19 pandemic and political conflicts have affected the accessibility of key raw materials, disrupting production and supply. The market also confronts increased competition in the form of competing bleeding control technologies, for instance, electrosurgical products and new-generation sutures that enable effective hemostasis for most procedures. In addition, moral issues surrounding the use of animal-derived hemostatic products are shaping regulatory constraints and encouraging research into synthetic equivalents, which are subject to exhaustive research and clinical testing. Regulatory hurdles in terms of rigorous clinical trials and new product development cost pose additional slowing factors. There are also intellectual property issues and patent litigation challenges that companies need to overcome before they can launch novel hemostats. Conquering these obstacles will involve robust R&D spending, regulatory partnerships, and creative supply chain approaches to facilitate long-term market expansion.
By Type
The oxidized regenerated cellulose-based hemostats segment led the market in 2023 with a market share of 43.9%. This is due to its better biocompatibility, faster absorption, and efficacy in stopping bleeding in all types of surgeries. Its simplicity of use and lower risk of complications have also made it highly adopted by surgeons.
The combination hemostats segment will be the growth leader, supported by the increasing demand for multi-mechanism hemostatic products that maximize clotting effectiveness. The rising incidence of complicated surgeries and trauma cases demanding high-end hemostatic products is also driving demand.
By Formulation
Matrix & gel hemostats segment was the largest in terms of revenue share with 37.9% in 2023 owing to its robust bonding to the surface of the wound, simple application, and improved hemostatic effects. These formulations find maximum usage in surgeries involving high precision because they achieve localized hemostasis with no impact on the adjacent tissue.
The sponge hemostats segment is anticipated to see the most growth, due to its growing application in minimally invasive and laparoscopic surgeries. Sponge-based hemostats' property of conforming to irregular surfaces and quick absorption makes them ever more sought after in sophisticated surgery environments.
By Application
The orthopedic surgery segment commanded the highest market share of 30.01% during 2023 due to the large volume of orthopedic procedures, including joint replacements, spinal surgeries, and trauma-related procedures. The rising number of bone fractures and sports injuries has also driven the demand for hemostatic agents in this segment.
The cardiovascular surgery segment is expected to expand at the highest rate, mainly because of the growing incidence of cardiovascular diseases and an increase in open-heart and vascular surgeries. The need for effective bleeding control solutions in such high-stakes surgeries is likely to drive the adoption of advanced hemostats.
By End-use
The hospitals & clinics segment held the largest market share in 2023 at 45.02% of the total revenue share. This is due to the large number of surgical procedures being conducted within hospitals, mature healthcare infrastructure, and access to sophisticated surgical equipment. Hospitals also possess greater purchasing power and can therefore afford to invest in high-quality hemostatic products.
The casualty care centers segment is expected to have the highest growth rate, owing to the surging demand for emergency trauma treatment and the increased use of hemostatic products in first-response medical environments. The growth in specialized trauma centers and battlefield medical units is also driving this fast growth.
North America led the hemostats market in 2023, with a share of 33.06% of the total market. The region's dominance is based on a large number of surgical procedures, superior healthcare infrastructure, and robust reimbursement policies favoring the use of novel hemostatic products. The region is home to a high population base of elderly patients susceptible to chronic ailments, thus witnessing a high volume of surgeries, especially cardiovascular, orthopedic, and general surgical. Moreover, the availability of key market players like Baxter, Johnson & Johnson, and Medtronic guarantees constant innovation in product lines and global availability of hemostatic solutions. The rising number of trauma cases and emergency procedures, coupled with a greater inclination towards minimally invasive surgeries, also fuels market growth in North America.
The Asia-Pacific region is expected to be the most rapidly growing hemostats market due to accelerated healthcare infrastructure growth, rising surgical volumes, and an aging population in nations like China, India, and Japan. The region is also seeing increased investment in healthcare, government programs to enhance surgical care, and the increasing use of advanced hemostatic products. In addition, the growing presence of foreign manufacturers and rising awareness of surgeons regarding the advantages of hemostats are likely to stimulate strong market growth in the region.
Johnson & Johnson – SURGICEL, EVICEL, SURGIFLO
CryoLife, Inc (Artivion) – PerClot, BioGlue
Integra LifeSciences Corporation – SurgiMend, DuraGen
Pfizer – Tisseel, Floseal
B. Braun Melsungen AG – Aesculap Hemostat, Coseal
Becton, Dickinson, and Company (BD) – Arista AH, Instat
Medtronic – Recothrom, Veriset
Baxter – Tisseel, Hemopatch
Stryker Corporation – SealFoam, HyperBranch
Z-Medica (Acquired by Teleflex) – QuikClot, HemCon
In Sep 2024, Medcura, Inc. announced that its LifeGel Absorbable Hemostatic Gel has won the 2024/2025 Best Technology in Spine Award. This recognition highlights Medcura’s advancements in biopolymer-based hemostatic solutions for surgical bleeding control.
In July 2023, Baxter International Inc. launched PERCLOT Absorbable Hemostatic Powder in the U.S., marking its first passive hemostat in the region. This addition expands Baxter’s portfolio to include both active and passive hemostatic solutions, catering to mild bleeding in patients with intact coagulation.
In March 2023, Axio Biosolutions, a Bengaluru-based medtech company, received US FDA 510(k) clearance for Ax-Surgi Surgical Hemostat, making it the first chitosan-based hemostat approved for controlling severe surgical bleeding. Ax-Surgi, built on a novel biopolymer platform, is designed for temporary control of internal organ space bleeding in Class III and IV hemorrhage, as well as severe surgical and traumatic wounds.
| Report Attributes | Details |
| Market Size in 2023 | USD 2.74 billion |
| Market Size by 2032 | USD 4.93 billion |
| CAGR | CAGR of 6.76% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type [Thrombin-based Hemostats, Oxidized Regenerated Cellulose-based Hemostats, Combination Hemostats, Others] • By Formulation [Matrix & Gel Hemostats, Sponge Hemostats, Powder Hemostats, Others] • By Application [Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Others] • By End-use [Hospitals & Clinics, Ambulatory Surgical Centers (ASCs), Casualty Care Centers, Others] |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Johnson & Johnson, CryoLife, Inc (Artivion), Integra LifeSciences Corporation, Pfizer, B. Braun Melsungen AG, Becton, Dickinson, and Company (BD), Medtronic, Baxter, Stryker Corporation, Z-Medica (Teleflex). |
Ans: The rising number of surgical procedures worldwide, increasing demand for advanced bleeding control solutions, and the growing prevalence of chronic conditions.
Ans: One of the major challenges in the hemostats market is the difficulty in achieving consistent product performance across different surgical conditions.
Ans: The Hemostats Market Size was valued at USD 2.74 billion in 2023 and is expected to reach USD 4.93 billion by 2032 and grow at a CAGR of 6.76% over the forecast period 2024-2032.
Ans: North America is dominating the market.
Ans: The market is divided into four segments.
Table Of Contents:
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Surgeries & Trauma Cases (2023)
5.2 Prescription and Utilization Trends of Hemostats (2023), by Region
5.3 Healthcare Spending on Hemostatic Products, by Region (Government, Commercial, Private, Out-of-Pocket) (2023)
5.4 R&D Investments and Innovations in Hemostats (2023-2032)
5.5 Impact of Regulatory Policies and Safety Guidelines on Hemostats Market (2023-2032)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and Promotional Activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Hemostats Market Segmentation, by Type
7.1 Chapter Overview
7.2 Thrombin-based Hemostats
7.2.1 Thrombin-based Hemostats Market Trends Analysis (2020-2032)
7.2.2 Thrombin-based Hemostats Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Oxidized Regenerated Cellulose-based Hemostats
7.3.1 Oxidized Regenerated Cellulose-based Hemostats Market Trends Analysis (2020-2032)
7.3.2 Oxidized Regenerated Cellulose-based Hemostats Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Combination Hemostats
7.4.1 Combination Hemostats Market Trends Analysis (2020-2032)
7.4.2 Combination Hemostats Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Others
7.5.1 Others Market Trends Analysis (2020-2032)
7.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Hemostats Market Segmentation, By Formulation
8.1 Chapter Overview
8.2 Matrix & Gel Hemostats
8.2.1 Matrix & Gel Hemostats Market Trends Analysis (2020-2032)
8.2.2 Matrix & Gel Hemostats Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Sponge Hemostats
8.3.1 Sponge Hemostats Market Trends Analysis (2020-2032)
8.3.2 Sponge Hemostats Market Size Estimates And Forecasts To 2032 (USD Billion)
8.4 Powder Hemostats
8.4.1 Powder Hemostats Market Trends Analysis (2020-2032)
8.4.2 Powder Hemostats Market Size Estimates And Forecasts To 2032 (USD Billion)
8.5 Others
8.5.1 Others Market Trends Analysis (2020-2032)
8.5.2 Others Market Size Estimates And Forecasts To 2032 (USD Billion)
9. Hemostats Market Segmentation, by Application
9.1 Chapter Overview
9.2 Orthopedic Surgery
9.2.1 Orthopedic Surgery Market Trends Analysis (2020-2032)
9.2.2 Orthopedic Surgery Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 General Surgery
9.3.1 General Surgery Market Trends Analysis (2020-2032)
9.3.2 General Surgery Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Neurological Surgery
9.4.1 Neurological Surgery Market Trends Analysis (2020-2032)
9.4.2 Neurological Surgery Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Cardiovascular Surgery
9.5.1 Cardiovascular Surgery Market Trends Analysis (2020-2032)
9.5.2 Cardiovascular Surgery Market Size Estimates and Forecasts to 2032 (USD Billion)
9.6 Others
9.6.1 Others Market Trends Analysis (2020-2032)
9.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Hemostats Market Segmentation, By End-use
10.1 Chapter Overview
10.2 Hospitals & Clinics
10.2.1 Hospitals & Clinics Market Trends Analysis (2020-2032)
10.2.2 Hospitals & Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
10.3 Ambulatory Surgical Centers (ASCs)
10.3.1 Ambulatory Surgical Centers (ASCs) Market Trends Analysis (2020-2032)
10.3.2 Ambulatory Surgical Centers (ASCs) Market Size Estimates and Forecasts to 2032 (USD Billion)
10.4 Casualty Care Centers
10.4.1 Casualty Care Centers Market Trends Analysis (2020-2032)
10.4.2 Casualty Care Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
10.5 Others
10.5.1 Others Market Trends Analysis (2020-2032)
10.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
11. Regional Analysis
11.1 Chapter Overview
11.2 North America
11.2.1 Trends Analysis
11.2.2 North America Hemostats Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.2.3 North America Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.2.4 North America Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.2.5 North America Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.2.6 North America Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.2.7 USA
11.2.7.1 USA Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.2.7.2 USA Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.2.7.3 USA Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.2.7.4 USA Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.2.8 Canada
11.2.8.1 Canada Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.2.8.2 Canada Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.2.8.3 Canada Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.2.8.4 Canada Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.2.9 Mexico
11.2.9.1 Mexico Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.2.9.2 Mexico Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.2.9.3 Mexico Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.2.9.4 Mexico Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Trends Analysis
11.3.1.2 Eastern Europe Hemostats Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.3.1.3 Eastern Europe Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.4 Eastern Europe Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.3.1.5 Eastern Europe Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.6 Eastern Europe Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.3.1.7 Poland
11.3.1.7.1 Poland Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.7.2 Poland Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.3.1.7.3 Poland Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.7.4 Poland Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.3.1.8 Romania
11.3.1.8.1 Romania Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.8.2 Romania Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.3.1.8.3 Romania Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.8.4 Romania Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.3.1.9 Hungary
11.3.1.9.1 Hungary Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.9.2 Hungary Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.3.1.9.3 Hungary Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.9.4 Hungary Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.3.1.10 Turkey
11.3.1.10.1 Turkey Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.10.2 Turkey Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.3.1.10.3 Turkey Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.10.4 Turkey Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.3.1.11 Rest of Eastern Europe
11.3.1.11.1 Rest of Eastern Europe Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.11.2 Rest of Eastern Europe Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.3.1.11.3 Rest of Eastern Europe Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.11.4 Rest of Eastern Europe Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.3.2 Western Europe
11.3.2.1 Trends Analysis
11.3.2.2 Western Europe Hemostats Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.3.2.3 Western Europe Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.4 Western Europe Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.3.2.5 Western Europe Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.6 Western Europe Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.3.2.7 Germany
11.3.2.7.1 Germany Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.7.2 Germany Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.3.2.7.3 Germany Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.7.4 Germany Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.3.2.8 France
11.3.2.8.1 France Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.8.2 France Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.3.2.8.3 France Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.8.4 France Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.3.2.9 UK
11.3.2.9.1 UK Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.9.2 UK Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.3.2.9.3 UK Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.9.4 UK Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.3.2.10 Italy
11.3.2.10.1 Italy Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.10.2 Italy Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.3.2.10.3 Italy Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.10.4 Italy Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.3.2.11 Spain
11.3.2.11.1 Spain Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.11.2 Spain Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.3.2.11.3 Spain Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.11.4 Spain Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.3.2.12 Netherlands
11.3.2.12.1 Netherlands Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.12.2 Netherlands Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.3.2.12.3 Netherlands Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.12.4 Netherlands Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.3.2.13 Switzerland
11.3.2.13.1 Switzerland Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.13.2 Switzerland Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.3.2.13.3 Switzerland Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.13.4 Switzerland Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.3.2.14 Austria
11.3.2.14.1 Austria Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.14.2 Austria Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.3.2.14.3 Austria Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.14.4 Austria Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.3.2.15 Rest of Western Europe
11.3.2.15.1 Rest of Western Europe Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.15.2 Rest of Western Europe Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.3.2.15.3 Rest of Western Europe Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.15.4 Rest of Western Europe Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.4 Asia Pacific
11.4.1 Trends Analysis
11.4.2 Asia Pacific Hemostats Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.4.3 Asia Pacific Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.4 Asia Pacific Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.4.5 Asia Pacific Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.6 Asia Pacific Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.4.7 China
11.4.7.1 China Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.7.2 China Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.4.7.3 China Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.7.4 China Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.4.8 India
11.4.8.1 India Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.8.2 India Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.4.8.3 India Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.8.4 India Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.4.9 Japan
11.4.9.1 Japan Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.9.2 Japan Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.4.9.3 Japan Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.9.4 Japan Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.4.10 South Korea
11.4.10.1 South Korea Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.10.2 South Korea Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.4.10.3 South Korea Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.10.4 South Korea Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.4.11 Vietnam
11.4.11.1 Vietnam Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.11.2 Vietnam Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.4.11.3 Vietnam Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.11.4 Vietnam Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.4.12 Singapore
11.4.12.1 Singapore Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.12.2 Singapore Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.4.12.3 Singapore Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.12.4 Singapore Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.4.13 Australia
11.4.13.1 Australia Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.13.2 Australia Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.4.13.3 Australia Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.13.4 Australia Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.4.14 Rest of Asia Pacific
11.4.14.1 Rest of Asia Pacific Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.14.2 Rest of Asia Pacific Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.4.14.3 Rest of Asia Pacific Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.14.4 Rest of Asia Pacific Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.5 Middle East and Africa
11.5.1 Middle East
11.5.1.1 Trends Analysis
11.5.1.2 Middle East Hemostats Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.5.1.3 Middle East Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.4 Middle East Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.5.1.5 Middle East Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.6 Middle East Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.5.1.7 UAE
11.5.1.7.1 UAE Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.7.2 UAE Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.5.1.7.3 UAE Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.7.4 UAE Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.5.1.8 Egypt
11.5.1.8.1 Egypt Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.8.2 Egypt Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.5.1.8.3 Egypt Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.8.4 Egypt Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.5.1.9 Saudi Arabia
11.5.1.9.1 Saudi Arabia Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.9.2 Saudi Arabia Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.5.1.9.3 Saudi Arabia Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.9.4 Saudi Arabia Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.5.1.10 Qatar
11.5.1.10.1 Qatar Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.10.2 Qatar Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.5.1.10.3 Qatar Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.10.4 Qatar Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.5.1.11 Rest of Middle East
11.5.1.11.1 Rest of Middle East Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.11.2 Rest of Middle East Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.5.1.11.3 Rest of Middle East Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.11.4 Rest of Middle East Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.5.2 Africa
11.5.2.1 Trends Analysis
11.5.2.2 Africa Hemostats Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.5.2.3 Africa Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.2.4 Africa Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.5.2.5 Africa Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.2.6 Africa Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.5.2.7 South Africa
11.5.2.7.1 South Africa Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.2.7.2 South Africa Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.5.2.7.3 South Africa Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.2.7.4 South Africa Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.5.2.8 Nigeria
11.5.2.8.1 Nigeria Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.2.8.2 Nigeria Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.5.2.8.3 Nigeria Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.2.8.4 Nigeria Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.5.2.9 Rest of Africa
11.5.2.9.1 Rest of Africa Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.2.9.2 Rest of Africa Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.5.2.9.3 Rest of Africa Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.2.9.4 Rest of Africa Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.6 Latin America
11.6.1 Trends Analysis
11.6.2 Latin America Hemostats Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.6.3 Latin America Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.6.4 Latin America Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.6.5 Latin America Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.6.6 Latin America Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.6.7 Brazil
11.6.7.1 Brazil Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.6.7.2 Brazil Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.6.7.3 Brazil Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.6.7.4 Brazil Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.6.8 Argentina
11.6.8.1 Argentina Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.6.8.2 Argentina Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.6.8.3 Argentina Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.6.8.4 Argentina Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.6.9 Colombia
11.6.9.1 Colombia Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.6.9.2 Colombia Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.6.9.3 Colombia Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.6.9.4 Colombia Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11.6.10 Rest of Latin America
11.6.10.1 Rest of Latin America Hemostats Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.6.10.2 Rest of Latin America Hemostats Market Estimates and Forecasts, By Formulation (2020-2032) (USD Billion)
11.6.10.3 Rest of Latin America Hemostats Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.6.10.4 Rest of Latin America Hemostats Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
12. Company Profiles
12.1 Johnson & Johnson
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Product / Services Offered
12.1.4 SWOT Analysis
12.2 CryoLife, Inc (Artivion)
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Product / Services Offered
12.2.4 SWOT Analysis
12.3 Integra LifeSciences Corporation
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Product / Services Offered
12.3.4 SWOT Analysis
12.4 Pfizer
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Product / Services Offered
12.4.4 SWOT Analysis
12.5 B. Braun Melsungen AG
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Product / Services Offered
12.5.4 SWOT Analysis
12.6 Becton, Dickinson, and Company (BD)
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Product / Services Offered
12.6.4 SWOT Analysis
12.7 Medtronic
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Product / Services Offered
12.7.4 SWOT Analysis
12.8 Baxter
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Product / Services Offered
12.8.4 SWOT Analysis
12.9 Stryker Corporation
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Product / Services Offered
12.9.4 SWOT Analysis
12.10 Z-Medica (Teleflex)
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Product / Services Offered
12.10.4 SWOT Analysis
13. Use Cases and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Type
Thrombin-based Hemostats
Oxidized Regenerated Cellulose-based Hemostats
Combination Hemostats
Others
By Formulation
Matrix & Gel Hemostats
Sponge Hemostats
Powder Hemostats
Others
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Others
By End-use
Hospitals & Clinics
Ambulatory Surgical Centers (ASCs)
Casualty Care Centers
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The HIV Drugs Market size was valued at USD 32.7 Bn in 2023 and is estimated to reach USD 44.56 Bn by 2032 with a growing CAGR of 3.5% Over the Forecast Period of 2024-2032.
The Women’s Hormonal Supplements Market Size was valued at USD 4.50 Billion in 2023, and is expected to reach USD 8.50 Billion by 2032, and grow at a CAGR of 7.6% over the forecast period 2024-2032.
The U.S. Pharmacy Benefit Management Market was valued at USD 432.30 billion in 2023 and is expected to reach USD 947.90 billion by 2032 and grow at a CAGR of 9.13% over the forecast period 2024-2032.
The Urinary Drainage Bags Market size was valued at USD 1.80 Billion in 2023, expected to reach USD 2.64 Billion by 2032, grow at a CAGR of 4.38%.
The Pharmaceutical Filtration Market Size was valued at USD 16.4 billion in 2023 and is expected to reach USD 43.9 billion by 2032 with a growing CAGR of 11.56 % over the forecast period 2024-2032.
The Foot Orthotic Insoles Market was valued at USD 3.78 Billion in 2023 and projected to reach USD 6.87 Billion by 2032, growing at a 6.93% CAGR.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
